These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14670617)

  • 1. Insertion of an exogenous promoter in the E1A regulatory region of adenovirus does not disturb viral replication despite reduced E1A transcription.
    Yu L; Hamada K; Namba M; Kadomatsu K; Muramatsu T; Matsubara S; Tagawa M
    Cancer Lett; 2004 Jan; 203(1):51-7. PubMed ID: 14670617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restriction of adenoviral replication to the transcriptional intersection of two different promoters for colorectal and pancreatic cancer treatment.
    Hoffmann D; Wildner O
    Mol Cancer Ther; 2006 Feb; 5(2):374-81. PubMed ID: 16505112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
    Hoffmann D; Jogler C; Wildner O
    J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of replication-competent adenoviruses powered by an exogenous regulatory region is not linearly correlated with the viral infectivity/gene expression or with the E1A-activating ability but is associated with the p53 genotypes.
    Yamauchi S; Zhong B; Kawamura K; Yang S; Kubo S; Shingyoji M; Sekine I; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
    BMC Cancer; 2017 Sep; 17(1):622. PubMed ID: 28874135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
    J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
    Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
    Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
    Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
    Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication.
    Hernandez-Alcoceba R; Pihalja M; Qian D; Clarke MF
    Hum Gene Ther; 2002 Sep; 13(14):1737-50. PubMed ID: 12396626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral E1a expression levels affect virus-selective replication in human cancer cells.
    Zheng X; Rao XM; Snodgrass C; Wang M; Dong Y; McMasters KM; Zhou HS
    Cancer Biol Ther; 2005 Nov; 4(11):1255-62. PubMed ID: 16222119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of adenoviral gene expression by protein IX is not required for efficient virus replication.
    Sargent KL; Meulenbroek RA; Parks RJ
    J Virol; 2004 May; 78(10):5032-7. PubMed ID: 15113884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.
    Wirth T; Zender L; Schulte B; Mundt B; Plentz R; Rudolph KL; Manns M; Kubicka S; Kühnel F
    Cancer Res; 2003 Jun; 63(12):3181-8. PubMed ID: 12810646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc finger and carboxyl regions of adenovirus E1A 13S CR3 are important for transactivation of the cytomegalovirus major immediate early promoter by adenovirus.
    Sanchez TA; Habib I; Leland Booth J; Evetts SM; Metcalf JP
    Am J Respir Cell Mol Biol; 2000 Nov; 23(5):670-7. PubMed ID: 11062146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of E1A under an E2F-1 promoter insulated with the myotonic dystrophy locus insulator reduces the toxicity of oncolytic adenovirus Ad-Delta24RGD.
    Majem M; Cascallo M; Bayo-Puxan N; Mesia R; Germa JR; Alemany R
    Cancer Gene Ther; 2006 Jul; 13(7):696-705. PubMed ID: 16498429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Cell Cycle Facilitates E1A-Independent Adenoviral Replication.
    Ehrenfeld M; Segeth F; Mantwill K; Brockhaus C; Zhao Y; Ploner C; Kolk A; Gschwend JE; Nawroth R; Holm PS
    J Virol; 2023 Jun; 97(6):e0037023. PubMed ID: 37219458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus.
    Jing XJ; Kalman-Maltese V; Cao X; Yang Q; Trempe JP
    Virology; 2001 Dec; 291(1):140-51. PubMed ID: 11878883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome.
    Swaminathan S; Thimmapaya B
    J Mol Biol; 1996 May; 258(5):736-46. PubMed ID: 8637006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors.
    Hernandez-Alcoceba R; Pihalja M; Wicha MS; Clarke MF
    Hum Gene Ther; 2000 Sep; 11(14):2009-24. PubMed ID: 11020800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.